NO20010830D0 - Orale flytende mukoadhesive sammensetninger - Google Patents

Orale flytende mukoadhesive sammensetninger

Info

Publication number
NO20010830D0
NO20010830D0 NO20010830A NO20010830A NO20010830D0 NO 20010830 D0 NO20010830 D0 NO 20010830D0 NO 20010830 A NO20010830 A NO 20010830A NO 20010830 A NO20010830 A NO 20010830A NO 20010830 D0 NO20010830 D0 NO 20010830D0
Authority
NO
Norway
Prior art keywords
composition
safe
mixtures
effective amount
respiratory tract
Prior art date
Application number
NO20010830A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010830L (no
Inventor
Douglas Joseph Dobrozsi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20010830L publication Critical patent/NO20010830L/no
Publication of NO20010830D0 publication Critical patent/NO20010830D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010830A 1998-08-24 2001-02-19 Orale flytende mukoadhesive sammensetninger NO20010830D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9764698P 1998-08-24 1998-08-24
PCT/US1999/019201 WO2000010528A1 (fr) 1998-08-24 1999-08-24 Compositions mucoadhesives orales liquides

Publications (2)

Publication Number Publication Date
NO20010830L NO20010830L (no) 2001-02-19
NO20010830D0 true NO20010830D0 (no) 2001-02-19

Family

ID=22264456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010830A NO20010830D0 (no) 1998-08-24 2001-02-19 Orale flytende mukoadhesive sammensetninger

Country Status (18)

Country Link
US (2) US20020009478A1 (fr)
EP (1) EP1107732B1 (fr)
JP (1) JP2002523353A (fr)
KR (1) KR20010074834A (fr)
CN (1) CN1313754A (fr)
AT (1) ATE227978T1 (fr)
AU (1) AU753251B2 (fr)
BR (1) BR9913148A (fr)
CA (1) CA2338480C (fr)
CO (1) CO5140074A1 (fr)
DE (1) DE69904057T2 (fr)
DK (1) DK1107732T3 (fr)
ES (1) ES2185395T3 (fr)
HU (1) HUP0103217A2 (fr)
NO (1) NO20010830D0 (fr)
PE (1) PE20000863A1 (fr)
TR (1) TR200100569T2 (fr)
WO (1) WO2000010528A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
EP1997478B1 (fr) * 2001-02-15 2013-09-04 Access Pharmaceuticals, Inc. Formulations liquides pour la prévention et le traitement de maladies et troubles de la muqueuse
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
ES2195757B1 (es) * 2001-12-28 2005-03-01 Laboratorios Calier, S.A. Procedimiento para combatir las infestaciones de las colmenas de abejas.
AU2003222990B2 (en) * 2002-05-02 2009-11-12 Cragmont Pharmaceuticals, Llc Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
EP3308772B8 (fr) * 2002-06-28 2021-03-17 Civitas Therapeutics, Inc. Épinéphrine pouvant être inhalée
US6669929B1 (en) 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
DE10332486A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung akuter Schmerzen
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
WO2006009825A1 (fr) 2004-06-17 2006-01-26 Virun, Inc. Compositions comprenant une protéine adhérant aux muqueuses et principe actif pour la délivrance d'agents dans des muqueuses
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20060216359A1 (en) * 2005-03-25 2006-09-28 Lowell Riegel Topical preparation for treating ulcerations on the inside of the month
TR200803299T1 (tr) * 2005-11-10 2008-11-21 Century Biologicals Private Limited Solunum yolu rahatsızlıklarını tedavi etmek için kullanılan dengeli bir formülasyon.
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
FR2900824A1 (fr) * 2006-05-10 2007-11-16 Prod Dentaires Pierre Rolland Pate destinee a arreter les saignements, ses utilisations, et seringue la contenant
JP5230613B2 (ja) 2006-05-23 2013-07-10 テラコス・インコーポレイテッド グルコース輸送体阻害剤およびその使用方法
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US8748419B2 (en) 2006-06-16 2014-06-10 Theracos, Inc. Treating obesity with muscarinic receptor M1 antagonists
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
CN101138541B (zh) * 2006-09-06 2010-10-06 上海医药工业研究院 氨来占诺局部成膜凝胶组合物及其应用
DK2064222T3 (da) 2007-04-02 2014-07-21 Theracos Inc Benzyliske glycosid-derivater og fremgangsmåder til anvendelse deraf
RU2497526C2 (ru) 2007-08-23 2013-11-10 Теракос, Инк. Производные бензилбензола и способы их применения
US20090123570A1 (en) * 2007-11-09 2009-05-14 Warner W Randolph Composition and method for treating sore throat
MX349677B (es) 2007-11-13 2017-08-08 Meritage Pharma Inc Composiciones corticosteroides.
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
KR20210107137A (ko) 2008-04-21 2021-08-31 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
MX2011000637A (es) 2008-07-15 2011-05-02 Theracos Inc Derivados deuretados de bencilbenceno y metodos de uso.
CA2731769C (fr) 2008-07-21 2013-09-10 Otonomy, Inc. Compositions a liberation controlee modulant la structure otique et modulant le systeme immunitaire naturel et procedes de traitement de troubles otiques
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
HUE051538T2 (hu) 2008-08-20 2021-03-01 Univ California Kortikoszteroidok a gyomor-bél traktus gyulladásos betegségeinek kezelésére
SG193168A1 (en) 2008-08-22 2013-09-30 Theracos Inc Processes for the preparation of sglt2 inhibitors
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
AU2009324894B2 (en) 2008-11-25 2015-04-09 University Of Rochester MLK inhibitors and methods of use
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
EP2576549A4 (fr) 2010-05-24 2013-12-18 Univ Rochester Hétéroaryles bicycliques formant inhibiteurs de la kinase et procédés d'utilisation
WO2011153712A1 (fr) 2010-06-12 2011-12-15 Theracos, Inc. Forme cristalline d'inhibiteur de sglt2 de type benzyl-benzène
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
WO2012112933A1 (fr) 2011-02-18 2012-08-23 The Scripps Research Institute Différenciation dirigée de cellules précurseurs d'oligodendrocytes vers un destin cellulaire myélinisant
US8524664B2 (en) 2011-06-02 2013-09-03 Colorado Seminary, Which owns and Operates The Univeristy of Denver Methods of treating overproduction of cortisol using ACTH antagonist peptides
PL2819699T3 (pl) 2012-02-27 2019-11-29 Bayer New Zealand Ltd Kompozycje o kontrolowanym uwalnianiu i sposoby ich zastosowania
WO2013188212A1 (fr) * 2012-06-15 2013-12-19 University Of New Hampshire Stimulant à base d'hydrogel à libération prolongée
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
EP2925319B1 (fr) 2012-11-30 2019-01-09 University Of Rochester Inhibiteurs de kinase de lignage mixte pour des thérapies pour le vih/sida
US11135158B2 (en) 2014-05-26 2021-10-05 Michael Lee Martin Medicated hard candy product for treating esophageal inflammation and a method using the same
ES2972665T3 (es) * 2015-03-26 2024-06-13 Patheon Softgels Inc Cápsulas liquisoft
AU2016298307A1 (en) 2015-07-28 2018-02-15 Otonomy, Inc. TrkB or TrkC agonist compositions and methods for the treatment of OTIC conditions
BR112018006199B1 (pt) 2015-09-28 2023-10-24 Evonik Operations Gmbh Composições orais antimicrobianas à base de sílica
CA3029281A1 (fr) 2016-06-29 2018-01-04 Otonomy, Inc. Formulations otiques a base de triglycerides et leurs utilisations
WO2019154895A1 (fr) 2018-02-08 2019-08-15 Strekin Ag Formulation en gel pour la prévention ou le traitement de la perte auditive
JP2022524486A (ja) * 2019-03-14 2022-05-06 イントラモント テクノロジーズ，インコーポレイテッド 口腔および咽頭を介して罹患する疾病の予防のための製剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US4042679A (en) * 1975-11-07 1977-08-16 Colgate-Palmolive Company Antibacterial oral composition
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation
EP0452334A4 (en) * 1989-10-31 1991-12-11 Watson Laboratoires, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JPH0639368B2 (ja) * 1990-02-28 1994-05-25 株式会社萩原技研 シリカゲルを母体とした抗菌性組生物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
WO1996021432A1 (fr) * 1995-01-11 1996-07-18 Cygnus, Inc. Administration de substances actives par les muqueuses pharyngiennes et ×sophagiennes
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
US5589160A (en) * 1995-05-02 1996-12-31 The Procter & Gamble Company Dentifrice compositions
US5658553A (en) * 1995-05-02 1997-08-19 The Procter & Gamble Company Dentifrice compositions
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
US20020009478A1 (en) * 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions

Also Published As

Publication number Publication date
CA2338480A1 (fr) 2000-03-02
US6638521B2 (en) 2003-10-28
CO5140074A1 (es) 2002-03-22
NO20010830L (no) 2001-02-19
DK1107732T3 (da) 2003-03-17
US20020009478A1 (en) 2002-01-24
JP2002523353A (ja) 2002-07-30
DE69904057T2 (de) 2003-08-21
ATE227978T1 (de) 2002-12-15
PE20000863A1 (es) 2000-09-12
EP1107732A1 (fr) 2001-06-20
CA2338480C (fr) 2004-10-05
WO2000010528A1 (fr) 2000-03-02
HUP0103217A2 (hu) 2001-12-28
ES2185395T3 (es) 2003-04-16
CN1313754A (zh) 2001-09-19
AU753251B2 (en) 2002-10-10
DE69904057D1 (de) 2003-01-02
AU5580899A (en) 2000-03-14
BR9913148A (pt) 2001-09-25
TR200100569T2 (tr) 2001-07-23
US20020076421A1 (en) 2002-06-20
KR20010074834A (ko) 2001-08-09
EP1107732B1 (fr) 2002-11-20

Similar Documents

Publication Publication Date Title
ATE300282T1 (de) Orale flüssige mucoadhäsive zusammensetzungen
ATE227978T1 (de) Orale flüssige mucoadhäsive zusammensetzungen
JPH0161086B2 (fr)
CA2323680A1 (fr) Comprimes se desintegrant dans la bouche
JPH03197430A (ja) 呼吸器管感染症用スプレー剤
ES2303645T3 (es) Composiciones para prevenir y tratar sintomas de tipo resfriado y gripe que comprenden cinc quelado.
FR2712807B1 (fr) Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
WO2003015746A1 (fr) Composition de nettoyage des voies nasales
WO2003101434A3 (fr) Compositions pharmaceutiques intranasales comprenant un antihistaminique et un inhibiteur de leucotrienes
ATE226429T1 (de) Orale flüssige mucoadhäsive zusammensetzungen
WO2001012128A3 (fr) Formes posologiques seches d'agents antibacteriens a usage topique pour traiter des infections aigues des muqueuses de la cavite buccale
JP2001139465A (ja) 咽頭粘膜用組成物
JP2002145764A (ja) 咽頭粘膜用組成物
GB2243548A (en) Therapeutic nasal drops containing sulphonamides
JP2007022971A (ja) 経鼻投与のための組成物
BR0205625C1 (pt) Formulações nasais em gel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application